Research projects

Research and new treatments

350

Around 350 children under 19 are diagnosed with cancer every year in Switzerland, and 35,000 in Europe.

1week

Every week, an average of 1 child dies of cancer in Switzerland. Cancer is the leading cause of death by disease among children and adolescents.

4sur5

Today, 4 out of 5 children survive, but often with serious after-effects due to their cancer treatment.

Research projects and new treatments funded by Zoé4life.

Since 2013, Zoé4life has funded research projects in Switzerland and abroad to the tune of over CHF 2,500,000.

Zoé4life also mobilizes research players in Switzerland and Europe. Zoé4life represents the voice of parents of children with cancer at international level within ITCC, ACCELERATE and Childhood Cancer International.

Projects financed in Switzerland

Hereditary predisposition to childhood cancers

Study on the need for communication tools

European study of relapsed retinoblastoma

INFORM2 NivEnt: a clinical trial for children with relapsing cancer

CAR-T Cell immunotherapy

Access to new treatments for children with cancer in Switzerland

A nurse coordinating studies on childhood cancer

International collaboration

To speed up the development of new treatments for childhood cancer, Zoé4life is involved at both Swiss and international level. Zoé4life has joined forces with other associations with similar aims. Together, we finance research projects in Europe and America.

Together, we're going to "solve" the problem of childhood cancer. By joining forces, we can make a difference for children with cancer.

Thanks to this partnership, we have financed the following projects:

ACTION Consortium: $2 million for research

TITAN, an innovative transatlantic project

Treating refractory neuroblastoma

Optimizing immunotherapy for refractory neuroblastoma

Childhood cancer has an impact on its victims and their families. An impact that is impossible to measure. However, funding decisions are often based on figures.

Here are a few facts about childhood cancer:

The causes of most pediatric cancers remain not only a mystery, but also unavoidable.

Childhood cancer is indiscriminate, sparing no ethnic group, socio-economic class or geographic region.

Around one in 600 young adults is a survivor of childhood cancer.

The average age of death of a child with cancer is 8 years, which represents a loss of around 69 years of probable life;
a significant loss of productivity for the company.

Pediatric cancer research must be a priority, and must progress more rapidly. Better-targeted treatments must be developed to cure more children and cure them better.

That's why Zoé4life is working at both Swiss and international level to make this a reality, in partnership with ITCC, ACCELERATE, SIOPENthe Swiss Pediatric Oncology Group, Solving Kids Cancerthe CHUVthe Kinderspital Zürich and theSeattle Children's Hospital.